ramucirumab,pembrolizumab
eli lilly,merck,medsir,
['s1800a', 'sclc', 'nsclc', 'improve', 'ramucirumab', 'medsir']
ramucirumab + pembro improves os compared to soc in pts with advanced nsclc treated w io &amp; prior platinum based chemo. great talk by on nonmatched substudy s1800a! #asco22 
Bring your idea to life?? 
Creating successful IITs & optimizing drug development ?? 
Medica Scientia Innovation Research
 ????&????
https://t.co/yp3O5Lylqc